Insider Transactions Reported by 20 Insiders of Nkarta, Inc.

Symbol
NKTX on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

Nkarta, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James Trager Chief Scientific Officer $845,370 18 Jun 2024
PAUL J. HASTINGS Chief Executive Officer, Director $572,923 -$41,436 -6.7% 18 Jun 2025
Nadir Mahmood President $477,151 05 Jun 2025
David Shook Chief Medical Officer, Head of Research & Development $420,101 -$19,004 -4.3% 15 Jan 2025
Alicia Hager Chief Legal Officer $322,817 -$21,085 -6.1% 15 Jan 2025
Ralph Brandenberger Chief Technical Officer $274,551 -$16,383 -5.6% 15 Jan 2025
Alyssa Levin Chief Financial and Business Officer $225,856 -$12,844 -5.4% 15 Jan 2025
Kanya Rajangam Chief Medical Officer $111,872 14 Jan 2022
Ali Behbahani Director 05 Jun 2025
Tiba Aynechi Director 08 Jun 2022
LEONE D. PATTERSON Director 05 Jun 2025
George Vratsanos Director 05 Jun 2025
Shawn Marshall Rose Chief Medical Officer, Head of Research & Development 23 Jun 2025
Michael Dybbs Director 05 Jun 2025
Angela Thedinga Director 05 Jun 2025
Laura Shawver Director 08 Jun 2022
Simeon George Director 05 Jun 2025
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner 05 Jun 2025
Zachary Scheiner Director 05 Jun 2025
Fouad Oscar Azzam Director 07 Jun 2023

Recent Insider Transactions by Companies or Individuals for Nkarta, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.